Korean J Urol.  2014 Feb;55(2):106-111. 10.4111/kju.2014.55.2.106.

Sedoanalgesia With Midazolam and Fentanyl Citrate Controls Probe Pain During Prostate Biopsy by Transrectal Ultrasound

• Tsuji FH
• Chambo RC
• Agostinho
• Trindade Filho JCS
• de Jesus C

• KMID: 1988435
• DOI: http://doi.org/10.4111/kju.2014.55.2.106

Abstract

PURPOSE
To assess the pain intensity of patients administered midazolam and fentanyl citrate before undergoing transrectal ultrasound-guided prostate biopsy.
MATERIALS AND METHODS
This was a study in patients with different indications for prostate biopsy in whom 5 mg of midazolam and 50 microg of fentanyl citrate was administered intravenously 3 minutes before the procedure. After biopsy, pain was assessed by use of a visual analogue scale (VAS) in three stages: VAS 1, during probe introduction; VAS 2, during needle penetration into prostate tissue; and VAS 3, in the weeks following the exam. Pain intensity at these different times was tested with stratification by age, race, education, prostate volume, rebiopsy, and anxiety before biopsy. Pain was ranked according to the following scores: 0 (no pain), 1-3 (mild pain), 4-7 (moderate pain), and 8-10 (severe pain). Statistical analysis was performed by using Kruskal-Wallis and Wilcoxon two-tailed tests with a significance of 5%.
RESULTS
Pain intensity was not influenced by any risk factors. The mean VAS 1 score was 1.95+/-1.98, the mean VAS 2 score was 2.73+/-2.55, and the mean VAS 3 score was 0.3+/-0.9, showing greater pain at the time of needle penetration than in other situations (VAS 2>VAS 1>VAS 3, p=0.0013, p=0.0001, respectively). Seventy-five percent of patients reported a VAS pain scale of less than 3.1 or mild pain.
CONCLUSIONS
Intravenous sedation and analgesia with midazolam and fentanyl citrate is a good method for reducing pain caused by prostate biopsy, even during probe insertion.

Keyword

Anesthesia and analgesia; Needle biopsy; Pain measurement; Prostate

MeSH Terms

Analgesia
Anesthesia and Analgesia
Anxiety
Biopsy*
Biopsy, Needle
Continental Population Groups
Education
Fentanyl*
Humans
Midazolam*
Needles
Pain Measurement
Prostate*
Risk Factors
Ultrasonography*
Fentanyl
Midazolam

Reference

1. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012; 62:220–241.

2. Clements R, Aideyan OU, Griffiths GJ, Peeling WB. Side effects and patient acceptability of transrectal biopsy of the prostate. Clin Radiol. 1993; 47:125–126.

3. Collins GN, Lloyd SN, Hehir M, McKelvie GB. Multiple transrectal ultrasound-guided prostatic biopsies: true morbidity and patient acceptance. Br J Urol. 1993; 71:460–463.

4. Desgrandchamps F, Meria P, Irani J, Desgrippes A, Teillac P, Le Duc A. The rectal administration of lidocaine gel and tolerance of transrectal ultrasonography-guided biopsy of the prostate: a prospective randomized placebo-controlled study. BJU Int. 1999; 83:1007–1009.

5. Issa MM, Bux S, Chun T, Petros JA, Labadia AJ, Anastasia K, et al. A randomized prospective trial of intrarectal lidocaine for pain control during transrectal prostate biopsy: the Emory University experience. J Urol. 2000; 164:397–399.

6. Saad F, Sabbagh R, McCormack M, Peloquin F. A prospective randomized trial comparing lidocaine and lubricating gel on pain level in patients undergoing transrectal ultrasound prostate biopsy. Can J Urol. 2002; 9:1592–1594.

7. Irer B, Gulcu A, Aslan G, Goktay Y, Celebi I. Diclofenac suppository administration in conjunction with lidocaine gel during transrectal ultrasound-guided prostate biopsy: prospective, randomized, placebo-controlled study. Urology. 2005; 66:799–802.

8. Olmez G, Kaya S, Aflay U, Sahin H. Comparison of lornoxicam versus tramadol analgesia for transrectal prostate biopsy: a randomized prospective study. Int Urol Nephrol. 2008; 40:341–344.

9. Valero G, Gonzalez EU. Periprostatic anaesthesic infiltration for prostatic biopsy: a prospective, randomized, double blind and placebo-controlled study. Actas Urol Esp. 2005; 29:550–552.

10. Nash PA, Bruce JE, Indudhara R, Shinohara K. Transrectal ultrasound guided prostatic nerve blockade eases systematic needle biopsy of the prostate. J Urol. 1996; 155:607–609.

11. Autorino R, De Sio M, Di Lorenzo G, Damiano R, Perdona S, Cindolo L, et al. How to decrease pain during transrectal ultrasound guided prostate biopsy: a look at the literature. J Urol. 2005; 174:2091–2097.

12. Soloway MS, Obek C. Periprostatic local anesthesia before ultrasound guided prostate biopsy. J Urol. 2000; 163:172–173.

13. Adamakis I, Mitropoulos D, Haritopoulos K, Alamanis C, Stravodimos K, Giannopoulos A. Pain during transrectal ultrasonography guided prostate biopsy: a randomized prospective trial comparing periprostatic infiltration with lidocaine with the intrarectal instillation of lidocaine-prilocain cream. World J Urol. 2004; 22:281–284.

14. Arguelles Salido E, Congregado Ruiz CB, Conde Sanchez JM, Ruiz Zafra V, Medina Lopez RA, Campoy Martinez P. Ultrasound guided transrectal prostatic biopsy and pain. Prospective randomized study comparing lubricant gel, lidocaine gel, and anesthetic blockage of the neurovascular bundles with 1% lidocaine. Arch Esp Urol. 2008; 61:579–590.

15. Pareek G, Armenakas NA, Fracchia JA. Periprostatic nerve blockade for transrectal ultrasound guided biopsy of the prostate: a randomized, double-blind, placebo controlled study. J Urol. 2001; 166:894–897.

16. Barbosa RA, da Silva CD, Torniziello MY, Cerri LM, Carmona MJ, Malbouisson LM. A comparative study among three techniques of general anesthesia for ultrasound-guided transrectal prostate biopsy. Rev Bras Anestesiol. 2010; 60:457–465.

17. Peters JL, Thompson AC, McNicholas TA, Hines JE, Hanbury DC, Boustead GB. Increased patient satisfaction from transrectal ultrasonography and biopsy under sedation. BJU Int. 2001; 87:827–830.

18. Tobias-Machado M, Verotti MJ, Aragao AJ, Rodrigues AO, Borrelli M, Wroclawski ER. Prospective randomized controlled trial comparing three different ways of anesthesia in transrectal ultrasound-guided prostate biopsy. Int Braz J Urol. 2006; 32:172–179.

19. Song JH, Doo SW, Yang WJ, Song YS, Kim GW, Ku JH, et al. Value and safety of midazolam anesthesia during transrectal ultrasound-guided prostate biopsy. Korean J Urol. 2011; 52:216–220.

20. Kanto JH. Midazolam: the first water-soluble benzodiazepine. Pharmacology, pharmacokinetics and efficacy in insomnia and anesthesia. Pharmacotherapy. 1985; 5:138–155.

21. Jin SJ, Jung JY, Noh MH, Lee SH, Lee EK, Choi BM, et al. The population pharmacokinetics of fentanyl in patients undergoing living-donor liver transplantation. Clin Pharmacol Ther. 2011; 90:423–431.

22. American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology. 2002; 96:1004–1017.

23. Campbell WI, Lewis S. Visual analogue measurement of pain. Ulster Med J. 1990; 59:149–154.

24. Lopez-Corona E, Ohori M, Scardino PT, Reuter VE, Gonen M, Kattan MW. A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session. J Urol. 2003; 170(4 Pt 1):1184–1188.

25. de Jesus CM, Correa LA, Padovani CR. Complications and risk factors in transrectal ultrasound-guided prostate biopsies. Sao Paulo Med J. 2006; 124:198–202.

26. Westenberg AM, Cossar EH, Lorimer LB, Costello JP. The acceptability of transrectal ultrasound guided prostatic biopsy without anaesthesia. N Z Med J. 1999; 112:231–232.

27. Han KS, Lee KH. Korean Urologic Oncology Society Prostate Cancer Study Group. Factors influencing pain during transrectal ultrasonography-guided prostate biopsy. Prostate Cancer Prostatic Dis. 2008; 11:139–142.

28. McIntyre IG, Dixon A, Pantelides ML. Entonox analgesia for prostatic biopsy. Prostate Cancer Prostatic Dis. 2003; 6:235–238.

29. Izol V, Soyupak B, Seydaoglu G, Aridogan IA, Tansug Z. Three different techniques for administering analgesia during transrectal ultrasound-guided prostate biopsy: a comparative study. Int Braz J Urol. 2012; 38:122–128.